Primary tabs

Export products to Excel

Displaying 1 - 15 of 213
Product Alternative Name Development Status Target Mode Active Pharmaceutical Ingredient (API) Delivery Type Duration Type Project Stage Partner Updated date
11b-MNTDC / 11β/19/17β 11b-methyl-19-nortestosterone 17b-dodecylcarbonate (11b-MNTDC) Active Development Male Hormonal 11b-methyl-19-nortestosterone 17b-dodecylcarbonate Injectable, Oral BIOQUAL, Inc. 05/30/2018
3-DRIUD Active Development Female Non-hormonal Intrauterine Long-acting Pre-clinical Shandong Provincial Institute, China, Technology for Family Planning, China 07/28/2016
6-month DMPA DMPA-XT Active Development Female Hormonal medroxyprogesterone acetate Injectable Long-acting Phase I FHI 360 05/30/2018
Adjudin AF-2364 Active Development Male Non-hormonal 1-(2,4-dichlorobenzyl)-1H-indazole-3-carbohydrazide TBD Short-acting Lead Optimization Population Council 05/30/2018
ALDH1a2 Inhibitors Inhibitors of Testicular Retinoic Acid Biosynthesis Active Development Male Non-hormonal ALDH1A2 inhibitors Oral Long-acting Pre-clinical University of Washington, University of Minnesota 05/30/2018
Amphora® Gel Active Development Female Non-hormonal Lactic acid, Citric Acid, Potassium Bitartrate Vaginal Gel Pericoital Phase III Evofem, Inc. 05/30/2018
Androgen Restored Contraceptive ARC; triple hormone contraceptive; Triple OC Active Development Female Hormonal prasterone, estradiol, progesterone Oral Short-acting Phase II ANI Pharmaceuticals, Pantarhei Bioscience 05/30/2018
Annovera Nestorone®+ Ethinyl Estradiol One-Year Vaginal Ring SRA/WHO PQ Approved Female Hormonal nestorone, ethinyl estradiol Vaginal Ring Long-acting Marketed Population Council, NICHD, WHO, USAID, Bill & Melinda Gates Foundation, Avis and Clifford Barrus Medical Foundation 08/14/2018
Artificial Cryptorchidism Suspensories Inactive Male Non-hormonal Testicular Long-acting Phase II Centre Hospitalier Universitaire de Toulouse, France 05/30/2018
Bfree Duo Active Development Female Non-hormonal Barrier Pericoital Pre-clinical Women's Global Health Innovations 05/30/2018
Binding/Penetration Enzymes Active Development Male Non-hormonal Oral TBD Norfolk State University 05/30/2018
Biodegradable Foam Delivery System Active Development Female Non-hormonal Vaginal, Other Pericoital Target ID/Validation University of Cincinnati 05/30/2018
Biodegradable Implant with [Poly(PDL-co-DO)] Co-polymers Active Development Female Hormonal levonorgestrel Subdermal Long-acting Pre-clinical FHI 360, Yale University 05/30/2018
Biodegradable LNG-releasing Implant (Peking University) Female Hormonal levonorgestrel Subdermal Long-acting Pre-clinical Peking University, Institute of Biomedical Engineering at Chinese Academy of Medical College 05/30/2018
Biodegradable LNG-releasing Implant (SIPPR) Active Development Female Hormonal levonorgestrel Subdermal Long-acting Pre-clinical Shanghai Institute of Planned Parenthood Research (SIPPR) 05/30/2018
Export to Excel